Surrogate and modified endpoints for immunotherapy in advanced hepatocellular carcinoma. Lim M, Muquith M, Miramontes B, Lee CJ, et al. Hepatology 2023 Jun 1. doi: 10.1097/HEP.0000000000000494.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lim M, Muquith M, Miramontes B, Lee CJ, et al. Surrogate and modified endpoints for immunotherapy in advanced hepatocellular carcinoma. Hepatology 2023 Jun 1. doi: 10.1097/HEP.0000000000000494.
PMID: 37254559